Industries

Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...

TechVision's latest research service from the medical device technology cluster highlights the game changing innovations in cardiovascular care. Although cardiovascular devices have been in use for decades, over the last few years, there have been some major developments in cardiovascular care. The technology innoavtions are powered by rapid advanc...

The global healthcare industry is undergoing a transformation from being provider-centric to being more patient-centric by focusing more on the outcomes and value of care delivered. This Research Service (RS) extensively evaluates a business case for technologies that enable better hospital design and strategic business models for healthcare enterp...

This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...

The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...

Remote patient monitoring (RPM) is gaining momentum as a variety of factors create a significant need for the value propositions that RPM promises. The report states that the overall RPM market is expected to increase at a compound annual growth rate of 19.8% from 2017 to 2023. RPM refers to the use of telecommunications technology to enable pat...

he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

The healthcare market is a prime target of hackers looking for protected health information (PHI). The US Office of Civil Rights, which tracks major data security breaches in the healthcare space, reported at least 300 significant breaches in 2018 alone. This situation is exacerbated by the fact that the threat posed by hackers is increasing every...